Involvement of the modifier gene of a human mendelian disorder in a negative selection process

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Jéru, Isabelle ^a,b   Hayrapetyan, Hasmik ^c   Duquesnoy, Philippe ^a   Cochet, Emmanuelle ^a   Serre, Jean Louis ^d   Feingold, Josué ^a   Grateau, Gilles ^a   Sarkisian, Tamara ^c   Jeanpierre, Marc ^c   Amselem, Serge ^a,b  

^a Assistance publique Hôpitaux de Paris   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Armenia)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARMENIA; ARTICLE; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; KIDNEY AMYLOIDOSIS; RISK FACTOR; AMYLOIDOSIS; BIOLOGICAL MODEL; GENETIC SELECTION; GENETICS; HOMOZYGOTE; INFLAMMATION; MUTATION; NUCLEOTIDE SEQUENCE; STATISTICAL MODEL;

SERUM AMYLOID A;

AMYLOIDOSIS; ARMENIA; DNA MUTATIONAL ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; GENOTYPE; HOMOZYGOTE; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MODELS, GENETIC; MODELS, STATISTICAL; MUTATION; RISK FACTORS; SELECTION, GENETIC; SERUM AMYLOID A PROTEIN;

EID: 70449574423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007676     Document Type: Article

References (26)

1. Nadeau JH (2001) Modifier genes in mice and humans. Nat Rev Genet 2: 165-74.
2. Nadeau JH (2003) Modifier genes and protective alleles in humans and mice. Curr Opin Genet Dev 13: 290-5.
3. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, et al. (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67: 1136-43.
4. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, et al. (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48: 1149-55.
5. Akar N, Hasipek M, Akar E, Ekim M, Yalcinkaya F, et al. (2003) Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid 10: 12-6.
6. Medlej-Hashim M, Delague V, Chouery E, Salem N, Rawashdeh M, et al. (2004) Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet 5: 4.
7. Bakkaloglu A, Duzova A, Ozen S, Balci B, Besbas N, et al. (2004) Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population. J Rheumatol 31: 1139-42.
8. The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet 17: 25-31.
9. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 90: 797-807.
10. Zemer D, Pras M, Sohar E, Modan M, Cabili S, et al. (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314: 1001-5.
11. Rogers DB, Shohat M, Petersen GM, Bickal J, Congleton J, et al. (1989) Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet 34: 168-72.
12. Aivazian AA, Giulikekhvian NG, Zavgorodniaia AM, Abramian MK, Pashinian SA (1982) [Pathogenesis of amyloidosis in periodic disease]. Klin Med (Mosk) 60: 65-8.
13. Armenian HK, Khachadurian AK (1973) Familial paroxysmal polyserositis. Clinical and laboratory findings in 120 cases. J Med Liban 26: 605-14.
14. Schwabe AD, Peters RS (1974) Familial Mediterranean Fever in Armenians. Analysis of 100 cases. Medicine (Baltimore) 53: 453-62.
15. Kang S, HShin D (2004) The size of the chi-square test for the Hardy-Weinberg law. Hum Hered 58: 10-7.
16. Huber M, Chen Y, Dinwoodie I, Dobra A, Nicholas M (2006) Monte Carlo algorithms for Hardy-Weinberg proportions. Biometrics 62: 49-53.
17. Hartl DL, Clark AG (1997) Principles of population genetics. Sunderland: Sinauer Associates ed. 542 p.
18. Wahlund S (1928) Zusammensetzung von populationen und korrelationerscheinungen vom standpunkt der vererbungslehre aus betrachtet. Hereditas 11: 65-106.
19. Donabedian P, Mutafian C (1991) Artsakh: histoire du Karabakh. Paris: Paris Sevig Press. 174 p.
20. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, et al. (1999) MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65: 88-97.
21. Cazeneuve C, Hovannesyan Z, Genevieve D, Hayrapetyan H, Papin S, et al. (2003) Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 48: 2324-31.
22. Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G (2000) Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet 8: 367-71.
23. Zuniga J, Vargas-Alarcon G, Osnaya N, Martinez-Tripp S, Rodriguez-Reyna TS, et al. (1999) Heat-shock protein (HSP70-2) allelic frequencies in three distinct Mexican populations. Genes Immun 1: 66-8.
24. DeVry CG, Clarke S (1999) Polymorphic forms of the protein L-isoaspartate (D-aspartate) O-methyltransferase involved in the repair of age-damaged proteins. J Hum Genet 44: 275-88.
25. Luo X, Kranzler HR, Zuo L, Wang S, Schork NJ, et al. (2007) Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. Hum Mol Genet 16: 380-90.
26. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, et al. (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40: 1879-85.